Total Synthesis of ( )-Pepluanol B: Conformational Control of the Eight-Membered-Ring System

Pepluanol B is a bioactive diterpenoid isolated from the Euphorbia genus, known for its potential in treating autoimmune disorders like multiple sclerosis and asthma. Its structure features a rare [5-5-8-3] tetracyclic framework with six stereogenic centers, including a bridgehead quaternary center and a challenging cyclooctanone ring. These features make it a formidable target for total synthesis.

The authors developed a 20-step total synthesis starting from a known bicyclic diol. The primary challenge was the construction of the eight-membered ring and the precise installation of its stereocenters. Early attempts at the synthesis revealed that the orientation of the C14 carbonyl group was critical to the stereochemical outcome of subsequent steps, particularly the C13 methylation. Initial synthetic routes failed to produce the correct natural configuration because the cyclooctanone ring adopted an undesired conformation.

To overcome the conformational hurdle, the researchers utilized a bromo-epoxide as a temporary mask for the tertiary allylic alcohol. This strategy served two purposes: it protected the sensitive alcohol and increased the rigidity of the molecular backbone, which forced the cyclooctanone into the desired twist-boat conformation. This allowed for the successful installation of the C13 methyl group and the correct orientation of the C14 carbonyl. The synthesis was completed in both racemic and enantioenriched forms, with the latter achieved through lipase-catalyzed kinetic resolution of the starting material.

This work provides a robust method for accessing pepluanol B, enabling further biological studies of this promising therapeutic candidate. Beyond the specific target, the study demonstrates the power of using transient functional groups—like bromo-epoxides—to exert conformational control over flexible, medium-sized rings, a common bottleneck in the synthesis of complex natural products.